Abstracts tagged "biomarkers and cardiovascular disease"

Abstract Number: 2062 • 2018 ACR/ARHP Annual Meeting
Omentin-1: Potential Biomarker of Cardiovascular Risk in Axial Spondyloarthritis? a Serological and Genetic Study
Fernanda Genre¹, Javier Rueda-Gotor¹, Sara Remuzgo-Martínez¹, Verónica Pulito-Cueto¹, Alfonso Corrales¹, Verónica Mijares¹, Leticia Lera-Gómez¹, Virginia Portilla¹, Rosa Expósito², Cristina Mata², Iván Ferraz-Amaro³, M. Vanesa Hernandez-Hernandez⁴, Santos Castañeda⁵, Esther Vicente⁵, Cristina Fernández-Carballido⁶, María Paz Martínez-Vidal⁷, David Castro-Corredor⁸, Joaquín Anino-Fernández⁸, Ricardo Blanco¹, Oreste Gualillo⁹, Javier Martin¹⁰, Javier Llorca¹¹, Raquel Lopez-Mejías¹ and Miguel Angel González-Gay^1,12, ¹Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain, Santander, Spain, ²Rheumatology Division, Hospital Comarcal de Laredo, Laredo, Spain, ³Rheumatology Division, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, ⁴Rheumatology Division, Hospital Universitario de Canarias, La Laguna, Spain, ⁵Rheumatology Division, Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Spain, ⁶Rheumatology Division, Hospital General Universitario de Elda, Elda, Spain, ⁷Rheumatology Division, Hospital General Universitario de Alicante, Alicante, Spain, ⁸Rheumatology Division, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain, ⁹SERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), The NEIRID Group (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases), Santiago University Clinical Hospital, Santiago de Compostela, Spain, Santiago de Compostela, Spain, ¹⁰Instituto de Parasitología y Biomedicina ‘López-Neyra’, CSIC, PTS Granada, Granada, Spain., Granada, Spain, ¹¹Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain, ¹²School of Medicine, University of Cantabria, Santander, Spain, Santander, Spain
Background/Purpose: Cardiovascular (CV) disease (mainly due to accelerated atherosclerosis) is one of the main causes of mortality in axial spondyloarthritis (axSpA). The higher incidence of…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].